Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke Trials-Reference-Cited by-同舟云学术

Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke Trials

Published:2009-02 Issue:2 Volume:40 Page:577-581
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Philip Maria¹,Benatar Michael¹,Fisher Marc¹,Savitz Sean I.¹

Affiliation:

1. From the Department of Neurology (M.P., S.I.S.), University of Texas, Houston Medical School; the Department of Neurology (M.B.), Emory University, Atlanta, Ga; and the Department of Neurology (M.F.), University of Massachusetts Medical Center, Worcester, Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference62 articles.

1. Neuroprotection Does Not Work!

2. NXY-059 for the Treatment of Acute Ischemic Stroke

3. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: A need for more rigorous testing of neuroprotective agents in animal models of stroke

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing stroke recovery: unlocking the potential of cellular dynamics in stroke recovery;Cell Death Discovery;2024-07-11

2. Neuroprotection Afforded by an Enriched Mediterranean-like Diet Is Modified by Exercise in a Rat Male Model of Cerebral Ischemia;Antioxidants;2024-01-23

3. Drug testing;Translational Orthopedics;2024

4. Neuroprotection afforded by an enriched Mediterranean-like diet is modified by exercise in a rat model of cerebral ischemia;2023-10-23

5. Implications of MMP-12 in the pathophysiology of ischaemic stroke;Stroke and Vascular Neurology;2023-06-19